A Utah program allows AI chatbots to refill prescriptions, sparking medical debate. This initiative raises questions about AI regulation and patient safety measures. Doctors express concerns about potential risks and drug interactions with automated renewals. Some states are now exploring similar AI healthcare waivers and legislation. The program's future hinges on balancing innovation with established medical practices.

FDA is taking a hands-off approach

An AI program in the state of Utah has sparked a vigorous debate about the role of the technology in health care.